A meta-analysis identifies factors predicting the future development of freezing of gait in Parkinson’s disease
Giladi, N. et al. Motor blocks in Parkinson’s disease. Neurology 42, 333–339 (1992).
Google Scholar
Nutt, J. G. et al. Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet Neurol. 10, 734–744 (2011).
Google Scholar
Schaafsma, J. D. et al. Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson’s disease. Eur. J. Neurol. 10, 391–398 (2003).
Google Scholar
Bloem, B. R., Hausdorff, J. M., Visser, J. E. & Giladi, N. Falls and freezing of gait in Parkinson’s disease: a review of two interconnected, episodic phenomena. Mov. Disord. 19, 871–884 (2004).
Google Scholar
Giladi, N. Medical treatment of freezing of gait. Mov. Disord. 23, S482–S488 (2008).
Google Scholar
Okuma, Y. et al. A prospective study of falls in relation to freezing of gait and response fluctuations in Parkinson’s disease. Parkinsonism. Relat. Disord. 46, 30–35 (2018).
Google Scholar
Cui, C. K. & Lewis, S. J. G. Future therapeutic strategies for freezing of gait in Parkinson’s Disease. Front. Hum. Neurosci. 15, 741918 (2021).
Google Scholar
Ehgoetz Martens, K. A. et al. Behavioural manifestations and associated non-motor features of freezing of gait: a narrative review and theoretical framework. Neurosci. Biobehav. Rev. 116, 350–364 (2020).
Google Scholar
Weiss, D. et al. Freezing of gait: understanding the complexity of an enigmatic phenomenon. Brain 143, 14–30 (2020).
Google Scholar
Broeder, S. et al. Does transcranial direct current stimulation during writing alleviate upper limb freezing in people with Parkinson’s disease? A pilot study. Hum. Mov. Sci. 65, 142–153 (2019).
Chow, R., Tripp, B. P., Rzondzinski, D. & Almeida, Q. J. Investigating therapies for freezing of gait targeting the cognitive, limbic, and sensorimotor domains. Neurorehabil. Neural Repair 35, 290–299 (2021).
Google Scholar
Fietzek, U. M. et al. Levodopa changes the severity of freezing in Parkinson’s disease. Parkinsonism. Relat. Disord. 19, 894–896 (2013).
Google Scholar
Fonoff, E. T. et al. Spinal cord stimulation for freezing of gait: from bench to bedside. Front. Neurol. 10, 905 (2019).
Google Scholar
Gavriliuc, O. et al. Prediction of the effect of deep brain stimulation on gait freezing of Parkinson’s disease. Parkinsonism. Relat. Disord. 87, 82–86 (2021).
Google Scholar
Gilat, M. et al. A systematic review on exercise and training-based interventions for freezing of gait in Parkinson’s disease. Npj. Parkinsons. Dis. 7, 81 (2021).
Google Scholar
King, L. A. et al. Cognitively challenging agility boot camp program for freezing of gait in Parkinson Disease. Neurorehabil. Neural Repair 34, 417–427 (2020).
Google Scholar
Manor, B. et al. Multitarget transcranial electrical stimulation for freezing of gait: a randomized controlled trial. Mov. Disord. 36, 2693–2698 (2021).
Google Scholar
Nonnekes, J. et al. Freezing of gait: a practical approach to management. Lancet Neurol. 14, 768–778 (2015).
Google Scholar
Nonnekes, J., Bereau, M. & Bloem, B. R. Freezing of Gait and its Levodopa Paradox. JAMA Neurol. 77, 287–288 (2019).
Devos, D. et al. Methylphenidate : a treatment for Parkinson’s disease? CNS Drugs 27, 1–14 (2013).
Google Scholar
Moreau, C. et al. Methylphenidate for gait hypokinesia and freezing in patients with Parkinson’s disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial. Lancet Neurol. 11, 589–596 (2012).
Google Scholar
Pollak, L. et al. Low dose methylphenidate improves freezing in advanced Parkinson’s disease during off-state. J. Neural Transm. Suppl, 72, 145–148 (2007).
Henderson, E. J. et al. Rivastigmine for gait stability in patients with Parkinson’s disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 15, 249–258 (2016).
Google Scholar
Galna, B., Lord, S., Burn, D. J. & Rochester, L. Progression of gait dysfunction in incident Parkinson’s disease: impact of medication and phenotype. Mov. Disord. 30, 359–367 (2015).
Google Scholar
Ehgoetz Martens, K. A. et al. Predicting the onset of freezing of gait: A longitudinal study. Mov. Disord. 33, 128–135 (2018).
Google Scholar
Xu, K. et al. Constructing prediction models for freezing of gait by nomogram and machine learning: a longitudinal study. Front. Neurol. 12, 684044 (2021).
Google Scholar
Tang, X. et al. Association of sleep disturbance and freezing of gait in Parkinson disease: Prevention/delay implications. J. Clin. Sleep. Med. 17, 779–789 (2021).
Google Scholar
Chung, S. J. et al. Baseline cognitive profile is closely associated with long-term motor prognosis in newly diagnosed ParkinsonΓàùs disease. J. Neurol. 268, 4203–4212 (2021).
Google Scholar
Zhao, J. et al. Longitudinal prediction of freezing of gait in parkinson’s disease: a prospective cohort study. Front. Neurol. 12, 758580 (2021).
Lo, C. et al. Predicting motor, cognitive & functional impairment in Parkinson’s. Ann. Clin. Transl. Neurol. 6, 1498–1509 (2019).
Google Scholar
Chung, S. J. et al. White matter hyperintensities as a predictor of freezing of gait in Parkinson’s disease. Parkinsonism Relat. Disord. 66, 105–109 (2019).
Google Scholar
Djaldetti, R. et al. Can early dopamine transporter imaging serve as a predictor of Parkinson’s disease progression and late motor complications? J. Neurol. Sci. 390, 255–260 (2018).
Google Scholar
Kim, R. et al. Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson’s disease: an analysis of the PPMI cohort. Parkinsonism. Relat. Disord. 51, 49–54 (2018).
Google Scholar
Kim, R. et al. Apolipoprotein E4 genotype and risk of freezing of gait in Parkinson’s disease. Parkinsonism Relat. Disord. 81, 173–178 (2020).
Google Scholar
Dadar, M., Miyasaki, J., Duchesne, S. & Camicioli, R. White matter hyperintensities mediate the impact of amyloid b on future freezing of gait in Parkinson’s disease. Parkinsonism Relat. Disord. 85, 95–101 (2021).
Google Scholar
Kim, R. et al. CSF amyloid42 and risk of freezing of gait in early Parkinson disease. Neurology 92, 21 (2019).
Google Scholar
Tan, D. M. et al. Freezing of gait and activity limitations in people with Parkinson’s disease. Arch. Phys. Med Rehabil. 92, 1159–1165 (2011).
Google Scholar
Lopez, I. C., Ruiz, P. J., Del Pozo, S. V. & Bernardos, V. S. Motor complications in Parkinson’s disease: ten year follow-up study. Mov. Disord. 25, 2735–2739 (2010).
Google Scholar
Forsaa, E. B., Larsen, J. P., Wentzel-Larsen, T. & Alves, G. A 12-year population-based study of freezing of gait in Parkinson’s disease. Parkinsonism. Relat. Disord. 21, 254–258 (2015).
Google Scholar
Zhang, W. S., Gao, C., Tan, Y. Y. & Chen, S. D. Prevalence of freezing of gait in Parkinson’s disease: a systematic review and meta-analysis. J. Neurol. 268, 4138–4150 (2021).
Google Scholar
Cong, S. et al. Prevalence and clinical aspects of depression in Parkinson’s disease: a systematic review and meta‑analysis of 129 studies. Neurosci. Biobehav. Rev. 141, 104749 (2022).
Google Scholar
Quek, D. Y. L. et al. Validating a seated virtual reality threat paradigm for inducing anxiety and freezing of Gait in Parkinson’s Disease. J. Parkinsons. Dis. 11, 1443–1454 (2021).
Google Scholar
Gao, C., Liu, J., Tan, Y. & Chen, S. Freezing of gait in Parkinson’s disease: pathophysiology, risk factors and treatments. Transl. Neurodegener. 9, 12 (2020).
Google Scholar
Smulders, K. et al. Pharmacological treatment in Parkinson’s disease: effects on gait. Parkinsonism. Relat. Disord. 31, 3–13 (2016).
Google Scholar
Gilat, M. et al. Freezing of gait and levodopa. Lancet Neurol. 20, 505–506 (2021).
Google Scholar
Rajput, A. H. et al. Clinical-pathological study of levodopa complications. Mov. Disord. 17, 289–296 (2002).
Google Scholar
Koehler, P. J., Nonnekes, J. & Bloem, B. R. Freezing of gait before the introduction of levodopa. Lancet Neurol. 20, 97 (2021).
Google Scholar
Jansen, J. A. F. et al. Exploring the levodopa-paradox of freezing of gait in dopaminergic medication-naive Parkinson’s disease populations. Npj. Parkinsons. Dis. 9, 130 (2023).
Google Scholar
Chung, S. J. et al. Heterogeneous patterns of striatal dopamine loss in patients with young- versus old-onset parkinson’s disease: impact on clinical features. J. Mov. Disord. 12, 113–119 (2019).
Google Scholar
Bharti, K. et al. Neuroimaging advances in Parkinson’s disease with freezing of gait: a systematic review. Neuroimage. Clin. 24, 102059 (2019).
Google Scholar
Giladi, N. & Hausdorff, J. M. The role of mental function in the pathogenesis of freezing of gait in Parkinson’s disease. J. Neurol. Sci. 248, 173–176 (2006).
Google Scholar
Yang, N. et al. Impact of GBA variants on longitudinal freezing of gait progression in early Parkinson’s disease. J. Neurol. 270, 2756–2764 (2023).
Google Scholar
Li, K. et al. Development and validation of a nomogram for freezing of gait in patients with Parkinson’s Disease. Acta Neurol. Scand. 145, 658–668 (2022).
Google Scholar
Nonnekes, J. & Nieuwboer, A. Towards personalized rehabilitation for gait impairments in Parkinson’s Disease. J. Parkinsons. Dis. 8, S101–S106 (2018).
Google Scholar
Payami, H. The emerging science of precision medicine and pharmacogenomics for Parkinson’s disease. Mov. Disord. 32, 1139–1146 (2017).
Google Scholar
Riggare, S. & Hagglund, M. Precision medicine in Parkinson’s Disease – exploring patient-initiated self-tracking. J. Parkinsons. Dis. 8, 441–446 (2018).
Google Scholar
Straccia, G., Colucci, F., Eleopra, R. & Cilia, R. Precision medicine in Parkinson’s Disease: from genetic risk signals to personalized therapy. Brain Sci. 12, 1308 (2022).
Bode, M. et al. Multidomain cognitive training increases physical activity in people with Parkinson’s disease with mild cognitive impairment. Parkinsonism. Relat. Disord. 113, 105330 (2023).
Google Scholar
Geerlings, A. D. et al. Case management interventions in chronic disease reduce anxiety and depressive symptoms: a systematic review and meta-analysis. PLoS. One 18, e0282590 (2023).
Google Scholar
Rezazadeh Yazd, S. A. et al. Reducing depression and anxiety symptoms in patients with Parkinson’s disease: the effectiveness of group cognitive behavioral therapy. Parkinsonism. Relat. Disord. 112, 105456 (2023).
Google Scholar
Wong, P. L., Cheng, S. J., Yang, Y. R. & Wang, R. Y. Effects of dual task training on dual task gait performance and cognitive function in individuals with Parkinson Disease: a meta-analysis and meta-regression. Arch. Phys. Med. Rehabil. 104, 950–964 (2023).
Google Scholar
Allen, N. E. et al. Interventions for preventing falls in Parkinson’s disease. Cochrane Database Syst. Rev. 6, CD011574 (2022).
Google Scholar
Ernst, M. et al. Physical exercise for people with Parkinson’s disease: a systematic review and network meta-analysis. Cochrane Database Syst. Rev. 1, CD013856 (2023).
Google Scholar
Goh, L. et al. The effect of rehabilitation interventions on freezing of gait in people with Parkinson’s disease is unclear: a systematic review and meta-analyses. Disabil. Rehabil. 45, 3199–3218 (2023).
Ferrusola-Pastrana, A., Davison, G. & Meadows, S. N. The therapeutic effects of multimodal exercise for people with Parkinson’s: a longitudinal community-based study. Parkinsonism. Relat. Disord. 110, 105366 (2023).
Google Scholar
Johansson, M. E. et al. Aerobic exercise alters brain function and structure in Parkinson’s Disease: a randomized controlled trial. Ann. Neurol. 91, 203–216 (2022).
Google Scholar
Zhen, K. et al. A systematic review and meta-analysis on effects of aerobic exercise in people with Parkinson’s disease. Npj. Parkinsons. Dis. 8, 146 (2022).
Google Scholar
De Pablo-Fernandez, E., Lees, A. J., Holton, J. L. & Warner, T. T. Prognosis and neuropathologic correlation of clinical subtypes of Parkinson Disease. JAMA Neurol. 76, 470–479 (2019).
Google Scholar
Wells, G. A. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. (2014).
Andrade, C. Mean difference, Standardized Mean Difference (SMD), and their use in meta-analysis: as simple as it gets. J. Clin. Psychiatry 81, 20f13681 (2020).
Google Scholar
Higgins J. P. T. et al. (eds). Cochrane Handbook for Systematic Reviews of Interventions. Chichester (UK): John Wiley & Sons, version 6.3. (2022).
Banks, S. J. et al. Non-motor predictors of freezing of gait in Parkinson’s disease. Gait. Posture 68, 311–316 (2019).
Google Scholar
Chong, R. K., Lee, K. H., Morgan, J. & Wakade, C. Duration of step initiation predicts freezing in Parkinson’s disease. Acta Neurol. Scand. 132, 105–110 (2015).
Google Scholar
D’Cruz, N. et al. Repetitive motor control deficits most consistent predictors of conversion to freezing of gait in Parkinson’s Disease: a prospective cohort study. J. Parkinsons. Dis. 10, 559–571 (2020).
Google Scholar
Gallea, C. et al. Antisaccade, a predictive marker for freezing of gait in Parkinson’s disease and gait/gaze network connectivity. Brain 144, 504–514 (2021).
Google Scholar
Garcia-Ruiz, P. J. et al. What factors influence motor complications in parkinson disease? A 10-year prospective study. Clin. Neuropharmacol. 35, 1–5 (2012).
Google Scholar
Giladi, N. et al. Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology 56, 1712–1721 (2001).
Google Scholar
Herman, T. et al. Depressive symptoms may increase the risk of the future development of freezing of gait in patients with Parkinson’s disease: Findings from a 5-year prospective study. Parkinsonism. Relat. Disord. 60, 98–104 (2019).
Google Scholar
Jeong, S. H. et al. Neuropsychiatric burden is a predictor of early freezing and motor progression in drug-naive Parkinson’s Disease. J. Parkinsons. Dis. 11, 1947–1956 (2021).
Google Scholar
Jeong, S. H. et al. Does dopamine deficiency affect sex-dependent prognosis in Parkinson’s disease? Parkinsonism. Relat. Disord. 102, 57–63 (2022).
Google Scholar
Kelly, V. E. et al. Association of cognitive domains with postural instability/gait disturbance in Parkinson’s disease. Parkinsonism. Relat. Disord. 21, 692–697 (2015).
Google Scholar
Kim, Y. E. et al. Chronological view of peak and diphasic dyskinesia, wearing off and freezing of gait in Parkinson’s Disease. J. Parkinson’s Dis. 9, 741–747 (2019).
Google Scholar
Lee, J. J., Hong, J. Y. & Baik, J. S. Hyposmia may predict development of freezing of gait in Parkinson’s disease. J. Neural Transm. 128, 763–770 (2021).
Google Scholar
Ou, R. et al. Predictors of freezing of gait in Chinese patients with Parkinson’s disease. Brain Behav. 8, e00931 (2018).
Google Scholar
Prange, S. P. et al. Age and time course of long-term motor and nonmotor complications in Parkinson disease. Neurology 92, 73 (2019).
Google Scholar
Wang, F., Pan, Y., Zhang, M. & Hu, K. Predicting the onset of freezing of gait in Parkinson’s disease. Bmc. Neurol. 22, 213 (2022).
Google Scholar
Zhang, H. et al. A prospective study of freezing of gait with early Parkinson disease in Chinese patients. Medicine 95, e4056 (2016).
Google Scholar
Chung, S. J. et al. Initial motor reserve and long-term prognosis in Parkinson’s disease. Neurobiol. Aging 92, 1–6 (2020).
Google Scholar
Seok Jong, C. et al. Perivascular spaces in the basal ganglia and long-term motor prognosis in newly diagnosed Parkinson Disease. Neurology 96, e2121–e2131 (2021).
Google Scholar
D’Cruz, N. et al. Thalamic morphology predicts the onset of freezing of gait in Parkinson’s disease. Npj. Parkinsons. Dis. 7, 20 (2021).
Google Scholar
Kim, R. & Jeon, B. Serum neurofilament light chain predicts future freezing of gait in Parkinson’s disease. Parkinsonism. Relat. Disord. 91, 102–104 (2021).
Google Scholar
Li, N. et al. Brain network topology and future development of freezing of gait in Parkinson’s disease: a longitudinal study. J. Neurol. 269, 2503–2512 (2022).
Li, Y. et al. Baseline cerebral structural morphology predict freezing of gait in early drug-naive Parkinson’s disease. Npj. Parkinsons. Dis. 8, 176 (2022).
Google Scholar
Sarasso, E. et al. MRI biomarkers of freezing of gait development in Parkinson’s disease. Npj. Parkinsons. Dis. 8, 158 (2022).
Google Scholar
Wieler, M., Gee, M., Camicioli, R. & Martin, W. R. W. Freezing of gait in early Parkinson’s disease: Nigral iron content estimated from magnetic resonance imaging. J. Neurol. Sci. 361, 87–91 (2016).
Google Scholar
link